27 Feb’19

The Annual Intellectual Property Report to Congress: Risking 40% of GDP to Recoup 3%

| Posted in Blog | No comment

The Office of the U.S. Intellectual Property Enforcement Coordinator (IPEC) issued its Annual Intellectual Property Report to Congress this month (“Annual IP Report”). The Annual IP Report details the coordinated efforts of the White House, the Departments of Commerce, Justice, Homeland Security, State, Treasury, Health and Human Services, and Agriculture, the Office of the U.S. […]

Full article here
29 Jan’19

Helsinn v. Teva Decision: Secret Sales Qualify as Prior Art under the AIA

| Posted in Blog | No comment

The Supreme Court issued its decision on Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc. on January 22, 2019, upholding and applying the pre-AIA on-sale precedent to post-AIA matters. This holding establishes that a sale or offer to sell, including secret sales and sales that do not publicly disclose the details of the invention, […]

Full article here
29 Nov’18

FIRRMA and its Impact on That Which it Seeks to Protect

| Posted in Blog | No comment

The Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA) was signed into law by the current Administration on August 13, 2018, to protect US technological superiority and address national security risks associated with the ability of foreign parties to obtain equity interests in domestic businesses and influence decisions or obtain information related to critical […]

Full article here